index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

86

 

NOTICES

151

 

 

MOTS CLES

Acute Myeloid Leukaemia AML Antimicrobiens Sipuleucel-T Adverse side effects Antibiotics Immune-related adverse events Epidemiology Adolescent Antibiotic resistance Primary adrenal insufficiency Ustekinumab Anti-Bacterial Agents Burden Cardiomyopathy Biological Therapy Pharmaco-Épidémiologie Biological therapy Meta-Analysis Stability Auto-Diagnostic Immune checkpoint inhibitors Biomédicaments Albinism Autoimmunity Arthritis Endocrine toxicity Psoriatic arthritis Ankylosing spondylitis Ethics Glucocorticoids COVID-19 ASDAS Antimicrobial Stewardship Atrial fibrillation Anti-TNF Prostate cancer Biologic drug Sacroiliitis BTK protein Méta-Analyse Apremilast Treatment Quality of life Cardio-oncology Bacterial rhinosinusitis Psoriasis Antibiotic misuse CTLA-4 Access to care Pharmacovigilance Angiotensin receptor blockers Alitretinoin Cancer ArtThese Adalimumab Ankylosing Atopic dermatitis Etanercept Biologics Drug survival Angiotensin-converting enzyme inhibitors Beta-lactam antibiotics Anxiety Azathioprine Graft-versus-host disease Anxiété Aging Arrhythmia Anti-HCV Direct Acting Antivirals DAA Calcium channel blockers Auto-immune hepatitis Autoimmune diseases Addiction Anticancer drugs Immunotherapy Antimicrobial resistance Abus d'antibiotiques Bacterial Axial spondyloarthritis Antimicrobials Amyloidosis Pharmacoepidemiology Vigibase® Spondyloarthritis Biomarkers CSK tyrosine-protein kinase Biologic Biologic therapy Alcohol Infliximab Accelerometer Biosimilar Pharmaceuticals Pregnancy Management Intensive care Cardiotoxicity Drug reaction Apre-milast Dermatology Placebo

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS